Hematopoietic stem cell transplantation from unrelated donors for acute leukemia

Blood

Volumn 112, Issue 2, 2008, Pages 447-448

  Mehta, Jayesh ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOTRANSPLANTATION; BLOOD DONOR; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME; ACUTE DISEASE; DONOR; LEUKEMIA; METHODOLOGY; NOTE;

ACUTE DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; TISSUE DONORS; TREATMENT OUTCOME;

EID: 47649110617     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-153122     Document Type: Letter

References (8)

1. Marks Dl, Pérez WS, He W, et al. Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. Blood. 2008;112:426.
2. Sirohi B, Powles R, Treleaven J, et al. The role of maintenance chemotherapy after autotransplantation for acute lymphoblastic leukemia in first remission: single-center experience of 100 patients. Bone Marrow Transplant. Prepublished on April 14, 2008, as doi 10.1038/bmt.2008.95.
3. Goldstone AH, Richards SM, Lazarus HM, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALLTrial (MRC UKALL XII/ECOG E2993). Blood. 2008;111:1827-1833.
4. Lazarus HM, Pérez WS, Klein JP, et al. Autotransplantation versus HLAmatched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research. Br J Haematol. 2006;132:755-769.
5. Bishop MR, Logan BR, Gandham S, et al. Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research. Bone Marrow Transplant. 2008;41:635-642.
6. Singhal S, Henslee-Downey PJ, Powles R, et al. Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission. Bone Marrow Transplant. 2003;31:889-895.
7. Singhal S, Powles R, Treleaven J, Kulkarni S, Horton C, Mehta J. Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling. Leuk Lymphoma. 1999;34:287-294.
8. Singhal S, Powles R, Treleaven J, Kulkarni S, Horton C, Mehta J. Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation. Bone Marrow Transplant. 1999;23:875-879.